Michael Stolpe is a Senior Economist at the Kiel Institute for the World Economy, in Germany, where he leads its global health research group. He is a founding member of the DFG-Cluster of Excellence "Precision Medicine," one of the world’s leading research collaborations on chronic inflammatory processes in the human body, associated with a wide range of diseases whose prevalence is rapidly increasing in many industrialized countries. Michael Stolpe is also a principal investigator in two interdisciplinary Leibniz Research Alliances – namely “INFECTIONS in an Urbanizing World – Humans, Animals, Environments (InfUrb),” where his contribution addresses the economics of antimicrobial resistance, and “Resilient Ageing,” where he explores sustainable health investment opportunities in ageing populations. Michael Stolpe’s other research is focused on health inequalities, investments in health over the lifecycle, early retirement and pension policy, the social costs of HIV/AIDS, medical decision making, and innovation in health technology and medical practice. From previous projects, he has additional expertise in venture capital finance, international economics and economic growth. His research has been reported and cited in leading German and international media outlets, such as Frankfurter Allgemeine Zeitung, Süddeutsche Zeitung, Basler Zeitung, Handelsblatt, Capital, Deutsche Welle, Deutschlandfunk, Norddeutscher Rundfunk, Tagesspiegel, Die Zeit, Die Welt, Der Spiegel, El País, and ARTE.TV, among others. He teaches health economics at the University of Kiel.
